Millennium Management’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,995
Closed -$25.4K 6370
2025
Q2
$25.4K Sell
23,995
-131,394
-85% -$129K ﹤0.01% 5665
2025
Q1
$169K Sell
155,389
-162,631
-51% -$221K ﹤0.01% 5343
2024
Q4
$480K Sell
318,020
-45,949
-13% -$72.8K ﹤0.01% 4783
2024
Q3
$542K Sell
363,969
-394,771
-52% -$610K ﹤0.01% 4763
2024
Q2
$1.23M Buy
758,740
+103,279
+16% +$186K ﹤0.01% 3957
2024
Q1
$1.11M Buy
+655,461
New +$1.22M ﹤0.01% 4204
2023
Q4
Sell
-28,549
Closed -$175K 6436
2023
Q3
$175K Sell
28,549
-101,990
-78% -$701K ﹤0.01% 5171
2023
Q2
$817K Sell
130,539
-211,613
-62% -$1.11M ﹤0.01% 4189
2023
Q1
$1.63M Buy
342,152
+268,615
+365% +$1.89M ﹤0.01% 3631
2022
Q4
$640K Sell
73,537
-86,959
-54% -$927K ﹤0.01% 4549
2022
Q3
$1.91M Buy
+160,496
New +$2.32M ﹤0.01% 3781
2022
Q1
Sell
-68,845
Closed -$1.59M 7355
2021
Q4
$1.59M Buy
+68,845
New +$1.66M ﹤0.01% 3974
2021
Q2
Sell
-7,560
Closed -$249K 6980
2021
Q1
$249K Buy
+7,560
New +$298K ﹤0.01% 5345
2020
Q4
Sell
-280,425
Closed -$9.96K 5503
2020
Q3
$9.96K Buy
+280,425
New +$10.3M 0.01% 1252

Other funds holding PMVP

Millennium Management's PMVP Position: Q3 2025 in Review

Millennium Management sold out of PMV Pharmaceuticals (PMVP) in Q3 2025, closing a stake of 23,995 shares — an estimated $25.4K sold.

Millennium Management first reported a position in PMVP in Q3 2020 and held it in 14 quarters. The position peaked at $1.91M in Q3 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • Millennium Management reported no remaining PMV Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 23,995 PMV Pharmaceuticals shares in Q3 2025, an estimated $25.4K.
  • Millennium Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 14 quarters.
  • Millennium Management's PMV Pharmaceuticals position peaked at $1.91M in Q3 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.